Effects of Enfonidipine Hydrochloride in Dogs with Experimental Supraventricular Tachyarrhythmia

Abstract

ABSTRACT. It is required not to increase the ventricular rate and to preserve the ventricular systolic function in treating supraventricular tachyarrhythmia (SVTA). The objective of this study is to investigate whether or not Efonidipine hydrochloride (EH), a T and L dual type Ca 2+ channel blocker, suppresses the increasing ventricular rate without reducing the ventricular systolic function using canine SVTA models by rapid atrial pacing (RAP) method. Clinically healthy fourteen beagles were used. The 14 dogs were randomly assigned to the EH-administered group (EH group, n=7) and non-EH-administered group (control group, n=7). The EH group was orally-administered EH at 5 mg/kg SID during RAP. On the other hand, the control group was applied RAP without oral administration of EH. Duration of RAP was for 3 weeks for both groups. The ventricular rate for the EH group was significantly lower than that for the control group. The left ventricular-fractional shortening for the control group declined significantly compared to baseline. Those for the EH group did not show any changes over time and were significantly higher than the control group. The ratio between pre-ejection period and ejection for the EH group were significantly lower than those of the control group. In conclusion, the study demonstrated that EH suppresses the increasing ventricular rate without reducing the ventricular systolic function in canine SVTA model. Therefore, EH is expected to become a new treatment for canine SVTA.KEY WORDS: arrhythmia, Ca 2+ channel blocker, canine, efonidipine hydrochloride.

Effects of cilostazol on the heart rate in healthy dogs

“…The Ao-PEP and Ao-ET were considered susceptible to the effects of the HR, and an increased HR reduced the Ao-PEP and Ao-ET, whereas a decreased HR reduced the Ao-PEP and Ao-ET [ 20 , 25 ]. Therefore, the ratio of Ao-PEP to Ao-ET (Ao-PEP/ET) has been used as an effective index for the clinical evaluation of ventricular contractility, as with FS [ 7 , 8 ]. No significant change was observed in the Ao-PEP/ET in this study, suggesting that the decreases in the Ao-PEP and Ao-ET resulted from an increase in the HR.…”

Comparative effects of amlodipine and benazepril on Left Atrial Pressure in Dogs with experimentally-induced Mitral Valve Regurgitation

“…Reduction of LAP is a desirable goal for drugs used to treat congestive heart failure in MVD. In general, calcium channel blockers are used for treatment of hypertrophic cardiomyopathy [5-7], atrial fibrillation [8-10], and systemic hypertension [11,12]. Amlodipine is a long acting 1,4-dihydropyridine calcium channel blocker, often used for treatment of systemic hypertension.…”

Comparison between blood coagulability in the intra-atrial and peripheral regions during the acute phase after rapid atrial pacing

“…Under general anesthesia, a pacing lead was implanted in the animals in accordance with the guidelines provided by Fukushima [9] and Gaspo et al [12]. In the present study, for stimulation of the atrium by RAP (2 mV, 390 bpm), artificial tachycardia was immediately triggered and maintained in the dog, and hemodynamics resembling the spontaneously developed similar to AF were obtained [9, 12] (Fig.…”